 |
PDBsum entry 4n36
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Sugar binding protein
|
PDB id
|
|
|
|
4n36
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Common polymorphisms in human langerin change specificity for glycan ligands.
|
 |
|
Authors
|
 |
H.Feinberg,
T.J.Rowntree,
S.L.Tan,
K.Drickamer,
W.I.Weis,
M.E.Taylor.
|
 |
|
Ref.
|
 |
J Biol Chem, 2013,
288,
36762-36771.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
|
|
 |
 |
|
Abstract
|
 |
|
Langerin, a C-type lectin on Langerhans cells, mediates carbohydrate-dependent
uptake of pathogens in the first step of antigen presentation to the adaptive
immune system. Langerin binds a diverse range of carbohydrates including high
mannose structures, fucosylated blood group antigens, and glycans with terminal
6-sulfated galactose. Mutagenesis and quantitative binding assays indicate that
salt bridges between the sulfate group and two lysine residues compensate for
the nonoptimal binding of galactose at the primary Ca(2+) site. A commonly
occurring single nucleotide polymorphism (SNP) in human langerin results in
change of one of these lysine residues, Lys-313, to isoleucine. Glycan array
screening reveals that this amino acid change abolishes binding to
oligosaccharides with terminal 6SO4-Gal and enhances binding to oligosaccharides
with terminal GlcNAc residues. Structural analysis shows that enhanced binding
to GlcNAc may result from Ile-313 packing against the N-acetyl group. The K313I
polymorphism is tightly linked to another SNP that results in the change N288D,
which reduces affinity for glycan ligands by destabilizing the Ca(2+)-binding
site. Langerin with Asp-288 and Ile-313 shows no binding to 6SO4-Gal-terminated
glycans and increased binding to GlcNAc-terminated structures, but overall
decreased binding to glycans. Altered langerin function in individuals with the
linked N288D and K313I polymorphisms may affect susceptibility to infection by
microorganisms.
|
 |
|
|
|
|
 |